Navigation Links
Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting

Surfaxin Phase 2 BPD Clinical Data Selected and Presented as Platform Presentation

Aerosurf Utilizing Chrysalis Aerosol-Generator Technology Demonstrates Optimal Functional Activity

WARRINGTON, Pa., May 8, 2007 (PRIME NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced that results from its previously completed Phase 2 clinical trial of Surfaxin(r) (lucinactant intratracheal suspension) for the prevention and treatment of Bronchopulmonary Dysplasia (BPD) were selected and presented as a platform presentation at the Pediatric Academic Societies' (PAS) Annual Meeting in Toronto, Canada. Also presented at PAS were data regarding Discovery's novel aerosolized KL-4 surfactant, Aerosurf(tm) (lucinactant for inhalation). The Pediatric Academic Societies' annual meeting is internationally recognized as the largest, most relevant medical meeting dedicated to pediatric critical care research. These data were presented for the first time to the medical community.

Phase 2 Clinical Trial of Surfaxin(r) for the Prevention and Treatment of BPD

Carl Bose, MD, Director of Neonatology and Professor of Pediatrics at University of North Carolina and Chairman of the Discovery BPD Clinical Study Steering Committee, presented an overview of key trial data. These data suggest that Surfaxin, when administered beyond the standard acute Respiratory Distress Syndrome (RDS) treatment period, may represent a novel therapeutic option for infants at risk for developing BPD. BPD is a chronic, debilitating lung disease affecting premature infants who survive treatment for RDS. Presently, there are no approved pharmaceutical therapies for BPD.

Surfaxin was shown to be generally safe and well-tolerated. Top-line results demonstrated that infants treated with up to five incremental standard doses of Surfaxin experienced:

* a lower incidence of death or BPD,

* a higher survival rate thr
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
3. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
10. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
(Date:7/1/2015)... July 1, 2015 Rock Creek Pharmaceuticals, Inc., ... on chronic inflammatory disease and neurologic disorders, announced today ... with anatabine citrate, the Company,s lead compound. Results from ... anatabine citrate can significantly inhibit the activation of inflammatory ... is developing this compound in a Phase 1 clinical ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... a new study Stationary Oxygen Concentrators Market ... markets are poised to achieve continuing growth as the ... develop COPD and other respiratory conditions where oxygen is ... a dramatic manner. Portable devices have become affordable and ...
(Date:7/1/2015)... DIEGO , July 1, 2015 OncoSec Medical ... intratumoral cancer immunotherapies, today announced that CEO and President ... celebration of the Company,s listing to The Nasdaq Stock Market ... Nasdaq MarketSite in New York City . ... employees, investors, and stakeholders, we are honored to open the ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 2OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 3
... releases of Elekta,s XiO® treatment planning system and Focal ... and deliver radiation therapy plans more efficiently. ... Therapy (IMRT) segmentation algorithm, fluence map smoothing and DICOM ... for contouring, enabling clinicians to contour anatomy faster and ...
... the vaccines division of Sanofi (EURONEXT: SAN and NYSE: ... 2011-2012 Fluzone® Influenza Virus Vaccine in the U.S. This shipment ... influenza vaccine the company plans to deliver to the U.S. ... producer of influenza vaccine in the U.S., supplying more than ...
Cached Medicine Technology:Latest Releases of Elekta's XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 3Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 4Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 5Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 6
(Date:7/1/2015)... ... July 01, 2015 , ... Ormco Corporation, ... that its fifth annual Smile for a Lifetime Foundation (S4L) fundraising event held ... In addition to supporting S4L in its mission to provide free quality orthodontic ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich ... for March 6th - 8th, the 2016 meeting will be held at the Westin ... of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse ... Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. ... rides, a petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses ...
(Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor ... at USF earning a Master’s degree in Microbiology. He graduated from the University of ... Dental Association, the Florida Dental Association and the Academy of General Dentistry. Dr. Williams ...
(Date:7/1/2015)... ... July 01, 2015 , ... Boar’s Head Brand®, one of ... for Independence Day celebrations with new takes on classic dishes. From chicken salad ... for any summertime get together. , “Celebrating with family, friends, and great food ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
... always a benefit, study of seniors suggests , THURSDAY, Jan. ... will kill you, a new Australian study finds that overweight ... die over a 10-year period than their normal-weight peers. , ... the American Geriatrics Society , conflicts with research that suggests ...
... , Crohn,s & Colitis Foundation of America Received ... During the 2009 Season , NEW YORK , ... (CCFA) today announced the culmination of the second consecutive year of ... David Garrard , quarterback of the Jacksonville Jaguars ® (1) and ...
... Dr. Diana Kirschner,s ... Men Play: 16 Men,s Deadly Dating Patterns that will help women either successfully DATE ... advice for single mothers, women over 45, successful professionals and African-Americans. , ... (PRWEB) January 28, 2010 -- A new year, ...
... ... has licensed Sunquest Collection Manager™ automated specimen collection software , ... (PRWEB) January 28, 2010 ... outreach solutions, announced that Valley Medical Center, in Renton, Washington, has licensed ...
... ... for the parents of disabled or special needs children in and around the Houston, TX area. ... attending one of our workshops. , ... (PRWEB) January 28, 2010 -- Bella’s House Community News is dedicated to supporting ...
... have identified several cytokines, cytokine-related factors, and chemokines that ... These findings confirm those of earlier studies which ... predicted and disease progression may be prevented. Complete findings ... of Arthritis & Rheumatism , a journal of ...
Cached Medicine News:Health News:Over 70 and Overweight May Add Years to Life 2Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 2Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 3Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 4Health News:New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them 2Health News:New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them 3Health News:Sunquest Information Systems Enters Into Business Relationship with Valley Medical Center of Washington 2Health News:Announcing the Launch of a New Workshop and Forum for Parents of Disabled Children 2Health News:Announcing the Launch of a New Workshop and Forum for Parents of Disabled Children 3Health News:Blood test can predict rheumatoid arthritis before symptoms arise 2
Industry leader in the design and manufacturing of GP Lenses. Abba holds the CLMA seal of excellence award....
... data collection and management ... multiple store environment. Home ... office with the stores ... and inventory reporting, recalls ...
This computerized retail software is aimed for opticians/optometrists, optical chains/1 hr superstores, optical HMOs, and ophthalmology groups....
... SDS Octoplus Ordering/Dispensing has gained recognition as ... lens ordering system. It enables opticians to ... using SDS electronic communications technology. When used ... or 3D frame tracers, lens shapes are ...
Medicine Products: